Barbara Vergani

521 total citations
17 papers, 385 citations indexed

About

Barbara Vergani is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Barbara Vergani has authored 17 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Pharmaceutical Science. Recurrent topics in Barbara Vergani's work include Histone Deacetylase Inhibitors Research (7 papers), Fluorine in Organic Chemistry (6 papers) and Chemical Synthesis and Analysis (4 papers). Barbara Vergani is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Fluorine in Organic Chemistry (6 papers) and Chemical Synthesis and Analysis (4 papers). Barbara Vergani collaborates with scholars based in Italy and Morocco. Barbara Vergani's co-authors include Giovanni Sandrone, Mattia Marchini, Andrea Stevenazzi, Pierfrancesco Bravo, Matteo Zanda, Marcello Crucianelli, Fiorenza Viani, Giorgio Bertolini, Gianluca Fossati and Stefano V. Meille and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Barbara Vergani

15 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Vergani Italy 9 251 223 89 52 49 17 385
Guillaume Mata United States 16 519 2.1× 288 1.3× 48 0.5× 27 0.5× 80 1.6× 24 760
Nada Jaber France 12 304 1.2× 115 0.5× 46 0.5× 20 0.4× 111 2.3× 24 389
Julian S. Northen United Kingdom 12 255 1.0× 201 0.9× 43 0.5× 113 2.2× 41 0.8× 22 403
Xicai Huang Canada 11 252 1.0× 183 0.8× 25 0.3× 22 0.4× 35 0.7× 18 373
David R. Bill United States 6 245 1.0× 163 0.7× 173 1.9× 11 0.2× 67 1.4× 7 363
Eugene A. Terefenko United States 14 499 2.0× 175 0.8× 30 0.3× 24 0.5× 53 1.1× 23 719
Emilia Naydenova Bulgaria 12 433 1.7× 187 0.8× 33 0.4× 79 1.5× 66 1.3× 59 599
Françis Beaulieu Canada 11 488 1.9× 231 1.0× 365 4.1× 30 0.6× 138 2.8× 11 668
David J. Dodsworth Spain 14 359 1.4× 278 1.2× 35 0.4× 17 0.3× 27 0.6× 24 448
Yi‐Yin Ku United States 16 459 1.8× 182 0.8× 36 0.4× 43 0.8× 95 1.9× 36 579

Countries citing papers authored by Barbara Vergani

Since Specialization
Citations

This map shows the geographic impact of Barbara Vergani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Vergani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Vergani more than expected).

Fields of papers citing papers by Barbara Vergani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Vergani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Vergani. The network helps show where Barbara Vergani may publish in the future.

Co-authorship network of co-authors of Barbara Vergani

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Vergani. A scholar is included among the top collaborators of Barbara Vergani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Vergani. Barbara Vergani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Scuteri, Arianna, Gabriella Nicolini, Alessio Malacrida, et al.. (2026). Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model. PAIN Reports. 11(2). e1395–e1395.
2.
Cavaletti, Guido, A Canta, A Chiorazzi, et al.. (2025). ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel. Toxics. 13(9). 767–767. 1 indexed citations
3.
Barbaglio, Federica, Daniela Belloni, Silvia Farè, et al.. (2025). Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro. Cell Reports Methods. 5(7). 101105–101105.
4.
Sandrone, Giovanni, Gianluca Fossati, Mattia Marchini, et al.. (2024). Mechanistic and Structural Insights on Difluoromethyl-1,3,4-oxadiazole Inhibitors of HDAC6. International Journal of Molecular Sciences. 25(11). 5885–5885. 6 indexed citations
5.
Fossati, Gianluca, Mattia Marchini, Giovanni Sandrone, et al.. (2023). The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors. Biology. 12(8). 1049–1049. 3 indexed citations
6.
Fossati, Gianluca, Mattia Marchini, Giovanni Sandrone, et al.. (2022). Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity. Journal of Biological Chemistry. 299(1). 102800–102800. 27 indexed citations
7.
Fossati, Gianluca, Pietro Pozzi, Elisabetta Galbiati, et al.. (2022). Abstract 1358: The selective HDAC6 inhibitor ITF3756 stimulates an antitumor immune response and leads to tumor regression in combination with anti CTLA-4 antibody in a colon carcinoma murine model. Cancer Research. 82(12_Supplement). 1358–1358. 1 indexed citations
8.
Pozzi, Pietro, Andrea Stevenazzi, Barbara Vergani, et al.. (2022). HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19. Frontiers in Immunology. 13. 841716–841716. 25 indexed citations
9.
Sandrone, Giovanni, Mattia Marchini, Barbara Vergani, et al.. (2021). Role of Fluorination in the Histone Deacetylase 6 (HDAC6) Selectivity of Benzohydroxamate-Based Inhibitors. ACS Medicinal Chemistry Letters. 12(11). 1810–1817. 21 indexed citations
10.
Stevenazzi, Andrea, et al.. (2014). Amino acidic scaffolds bearing unnatural side chains: An old idea generates new and versatile tools for the life sciences. Bioorganic & Medicinal Chemistry Letters. 24(23). 5349–5356. 135 indexed citations
11.
Volonterio, Alessandro, Pierfrancesco Bravo, Eleonora Corradi, et al.. (2001). Unusual nonchelation controlled allylation of a N -monoprotected α-amino aldehyde: stereoselective entry to nonracemic trifluoromethyl dipeptide isosteres. Journal of Fluorine Chemistry. 108(2). 245–252. 6 indexed citations
12.
Arnone, Alberto, Pierfrancesco Bravo, Massimo Frigerio, et al.. (1999). Synthesis of Enantiomerically Pure 2′,3′,5′-Trideoxy-4′-[(diethoxyphosphoryl)difluoromethyl]thymidine Analogues. European Journal of Organic Chemistry. 1999(9). 2149–2157. 7 indexed citations
13.
14.
Bravo, Pierfrancesco, Eleonora Corradi, Cristina Pesenti, et al.. (1998). Stereocontrolled approaches to (+)- and (−)-γ-trifluoromethyl-GABOB, a new hydroxymethylene (statine) dipeptide isostere. Tetrahedron Asymmetry. 9(21). 3731–3735. 19 indexed citations
15.
Volonterio, Alessandro, Barbara Vergani, Marcello Crucianelli, Matteo Zanda, & Pierfrancesco Bravo. (1998). (R)-Trifluoro- and Difluoropyruvaldehyde N,S-Ketals:  Chiral Synthetic Equivalents of β-Trifluoro and β-Difluoro α-Amino Aldehydes. The Journal of Organic Chemistry. 63(21). 7236–7243. 16 indexed citations
16.
Bertolini, Giorgio, et al.. (1998). A New Simple One-Pot Regioselective Preparation of Mixed Diesters of Carbonic Acid. The Journal of Organic Chemistry. 63(17). 6031–6034. 26 indexed citations
17.
Bravo, Pierfrancesco, Marcello Crucianelli, Barbara Vergani, & Matteo Zanda. (1998). Sulfinimines of trifluoropyruvate: Novel intermediates for chiral non racemic α-trifluoromethyl α-amino acids. Tetrahedron Letters. 39(42). 7771–7774. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillaume Mata Breakdown of academic impact, for papers by Nada Jaber Breakdown of academic impact, for papers by Julian S. Northen Breakdown of academic impact, for papers by Xicai Huang Breakdown of academic impact, for papers by David R. Bill Breakdown of academic impact, for papers by Eugene A. Terefenko Breakdown of academic impact, for papers by Emilia Naydenova Breakdown of academic impact, for papers by Françis Beaulieu Breakdown of academic impact, for papers by David J. Dodsworth Breakdown of academic impact, for papers by Yi‐Yin Ku
Rankless by CCL
2026